J&J Immunology President On Remicade, Inflectra And The Art Of Contract Negotiations

Janssen Biotech's Immunology President Scott White defended the company's Remicade contracting strategy in an interview and outlined why J&J believes it has been unfairly targeted in an anti-competitive lawsuit filed by rival Pfizer.